Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Phase 2 safety profile is consistent with the GLP-1 receptor agonist class, dominated by dose-dependent gastrointestinal adverse events that concentrate in the first one to two weeks of each escalation step
GLP-1 (glucagon-like peptide-1) is a hormone produced in the intestines that is vital for regulating blood sugar levels and appetite
7:e45825
While eating less helps create a calorie deficit, it can also lead to: Muscle loss Fatigue Hair thinning Nutrient deficiencies Constipation Slower metabolism That's why the goal isn't just to eat less
Accessed May 21, 2025.
Iwatani, S., Yamada, Y., & Usuda, Y
US$ 23.15
US$ 24.69
US$ 21.60
US$ 21.26
US$ 27.49
